We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Is the 10% EBITDA Margin Target Finally Within Reach for Chewy?
Read MoreHide Full Article
Key Takeaways
CHWY Q3 adjusted EBITDA grew 30% to $180.9M, with margin up 100 basis points to 5.8%.
CHWY targets a 10% EBITDA margin, with gains split between gross margin and expense leverage.
CHWY expects FY25 EBITDA margin of 5.6%-5.7%, backed by Autoship and ad revenue strength.
Chewy, Inc. (CHWY - Free Report) posted a steady year-over-year profitability improvement in the third quarter of 2025 and remains firmly on course to achieve its long-term target of a 10% adjusted EBITDA margin. Third-quarter performance built on the momentum from the first half of fiscal 2025 and highlighted the structural strength of Chewy’s business model. Initiatives like the expansion of Chewy Vet Care and the Chewy+ membership program are designed to deepen customer engagement and support long-term margin appreciation. The recent acquisition of SmartEquine is also expected to be accretive to margins upon closing.
Adjusted EBITDA increased 30% year over year to $180.9 million in the fiscal third quarter, with the adjusted EBITDA margin expanding 100 basis points to 5.8%. Management remains confident in Chewy’s ability to deliver consistent and sustainable EBITDA expansion in the years ahead. As of year-end, fewer than 450 basis points of improvement are remaining to reach this objective of 10% adjusted EBITDA margin target.
For fiscal 2025, management has narrowed its adjusted EBITDA margin guidance to 5.6%-5.7%, reflecting a year-over-year expansion of about 90 basis points. About 60% of this margin uplift is expected to stem from gross margin improvements, driven by high-margin contributors like sponsored ads, a shift toward premium categories, and the health ecosystem, with the remaining 40% coming from SG&A leverage. Gross margin increased by approximately 50 basis points year over year to 29.8% in the third quarter, supported by growth in sponsored advertising, a strong Autoship base and a favorable category mix. These improvements are expected to provide lasting structural margin benefits.
In addition, during the third quarter, Chewy generated 20 basis points of SG&A leverage year over year, excluding SBC and one-time items. This improvement reflects efficiencies from the scaling of the automated facility in Houston and the lapping of temporary costs tied to the Dallas FC and prior inventory pull-forward, signaling tighter cost discipline.
With accelerating margin expansion, improving cost discipline, and multiple structural profit drivers in place, Chewy appears increasingly well-positioned to steadily close the remaining gap and achieve its 10% adjusted EBITDA margin target.
Chewy Faces Competition From Petco & Bark
Petco Health & Wellness Company, Inc. (WOOF - Free Report) posted a 3.1% year-over-year decline in net sales to $1.5 billion in the third quarter of fiscal 2025, in line with the company’s outlook. Despite the revenue softness, adjusted EBITDA of Petco rose by $17.3 million to $98.6 million from $81.2 million, reflecting improved profitability, driven by effective cost management and operational execution in the quarter.
BARK, Inc.’s (BARK - Free Report) reported total revenues of $98.4 million, which declined 22.1% year over year due to fewer total orders stemming from a lower level of subscriptions carried into the third quarter of fiscal 2026. BARK reported an adjusted EBITDA loss of $1.6 million, within the company’s guidance of a loss of $1 million to $5 million.
From a valuation standpoint, CHWY trades at a forward price-to-earnings ratio of 30.5, higher than the industry’s average of 21.58.
Image Source: Zacks Investment Research
The Zacks Consensus Estimate for earnings estimates for the current and next fiscal years indicates year-over-year growth of 23.1% and 22.7%, respectively.
Image Source: Zacks Investment Research
Zacks' 7 Best Strong Buy Stocks (New Research Report)
Valued at $99, click below to receive our just-released report
predicting the 7 stocks that will soar highest in the coming month.
View the Zacks #1 Rank List
Image: Bigstock
Is the 10% EBITDA Margin Target Finally Within Reach for Chewy?
Key Takeaways
Chewy, Inc. (CHWY - Free Report) posted a steady year-over-year profitability improvement in the third quarter of 2025 and remains firmly on course to achieve its long-term target of a 10% adjusted EBITDA margin. Third-quarter performance built on the momentum from the first half of fiscal 2025 and highlighted the structural strength of Chewy’s business model. Initiatives like the expansion of Chewy Vet Care and the Chewy+ membership program are designed to deepen customer engagement and support long-term margin appreciation. The recent acquisition of SmartEquine is also expected to be accretive to margins upon closing.
Adjusted EBITDA increased 30% year over year to $180.9 million in the fiscal third quarter, with the adjusted EBITDA margin expanding 100 basis points to 5.8%. Management remains confident in Chewy’s ability to deliver consistent and sustainable EBITDA expansion in the years ahead. As of year-end, fewer than 450 basis points of improvement are remaining to reach this objective of 10% adjusted EBITDA margin target.
For fiscal 2025, management has narrowed its adjusted EBITDA margin guidance to 5.6%-5.7%, reflecting a year-over-year expansion of about 90 basis points. About 60% of this margin uplift is expected to stem from gross margin improvements, driven by high-margin contributors like sponsored ads, a shift toward premium categories, and the health ecosystem, with the remaining 40% coming from SG&A leverage. Gross margin increased by approximately 50 basis points year over year to 29.8% in the third quarter, supported by growth in sponsored advertising, a strong Autoship base and a favorable category mix. These improvements are expected to provide lasting structural margin benefits.
In addition, during the third quarter, Chewy generated 20 basis points of SG&A leverage year over year, excluding SBC and one-time items. This improvement reflects efficiencies from the scaling of the automated facility in Houston and the lapping of temporary costs tied to the Dallas FC and prior inventory pull-forward, signaling tighter cost discipline.
With accelerating margin expansion, improving cost discipline, and multiple structural profit drivers in place, Chewy appears increasingly well-positioned to steadily close the remaining gap and achieve its 10% adjusted EBITDA margin target.
Chewy Faces Competition From Petco & Bark
Petco Health & Wellness Company, Inc. (WOOF - Free Report) posted a 3.1% year-over-year decline in net sales to $1.5 billion in the third quarter of fiscal 2025, in line with the company’s outlook. Despite the revenue softness, adjusted EBITDA of Petco rose by $17.3 million to $98.6 million from $81.2 million, reflecting improved profitability, driven by effective cost management and operational execution in the quarter.
BARK, Inc.’s (BARK - Free Report) reported total revenues of $98.4 million, which declined 22.1% year over year due to fewer total orders stemming from a lower level of subscriptions carried into the third quarter of fiscal 2026. BARK reported an adjusted EBITDA loss of $1.6 million, within the company’s guidance of a loss of $1 million to $5 million.
Zacks Rundown for CHWY
CHWY shares have lost 25.6% in the last three months compared with the industry’s decline of 10.3%. Chewy carries a Zacks Rank #3 (Hold) at present. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Image Source: Zacks Investment Research
From a valuation standpoint, CHWY trades at a forward price-to-earnings ratio of 30.5, higher than the industry’s average of 21.58.
Image Source: Zacks Investment Research
The Zacks Consensus Estimate for earnings estimates for the current and next fiscal years indicates year-over-year growth of 23.1% and 22.7%, respectively.
Image Source: Zacks Investment Research